Top News

Jun 10, 2016
Results of a Phase II clinical trial reveal that stem-cell transplantation treatment following complete immune system destruction increases the duration of long-term remission in patients with multiple sclerosis.
Jun 06, 2016
An article in Nature Reviews Drug Delivery reports the clinical success rates of biologics, and these numbers differ from those recently highlighted in a similar BIO study.
Jun 02, 2016
As the battle for ownership over the use of CRISPR to edit DNA heats up, some of the CRISPR pioneers refocus their efforts to demonstrate the technology’s applications for editing RNA.
Jun 02, 2016
New pharmacovigilance activities seek to support the creation of guidelines for safe switching from innovator products to biosimilars.
May 25, 2016
In the largest-ever report of its kind, drugs entering clinical development in Phase I were found to have only a 1 in 10 chance of FDA approval.
May 25, 2016
By BioPharm International Editors
Sandoz is seeking approval for the same indications as Roche’s reference product MabThera.
May 24, 2016
By BioPharm International Editors
FDA accepted for review Samsung Bioepis’ BLA for SB2, a biosimilar to Remicade (infliximab).
May 19, 2016
A new study in Nature Communications explores how to remove the bulk of the soaps that are added to injectables to make hydrophobic drugs more soluble.
May 18, 2016
By BioPharm International Editors
The NIH and partners will launch a large-scale clinical trial in South Africa to evaluate the effectiveness of an HIV vaccine regimen
May 16, 2016
By BioPharm International Editors
Pfizer will acquire Anacor for $5.2 billion and expects the transaction to complete in the third-quarter of 2016.
native1_300x100
lorem ipsum